Lamin B1

Lamin B1
Name	Lamin B1
Uniprot	P20700
Organism	Homo sapiens
Length	664

Lamin B1 is a type V intermediate filament protein of the nuclear lamina that contributes to nuclear structure and genome organization. It is encoded by the LMNB1 gene and is evolutionarily conserved across metazoans, with homologs studied in Drosophila, Caenorhabditis elegans, and Mus musculus. Lamin B1 functions at the interface of chromatin, nuclear membrane dynamics, and signal transduction, implicated in development, cellular senescence, and neurological disease.

Structure and Biochemistry

Lamin B1 is a 664–716 amino acid protein in vertebrates composed of a central α-helical rod domain flanked by a N-terminal head and a C-terminal tail containing an immunoglobulin-like fold; comparable structural motifs are found in Desmin, Vimentin, and Keratin 18. The rod domain mediates parallel coiled-coil dimerization akin to Titin and Myosin heavy chain assemblies, enabling higher-order filament polymerization similar to cytoplasmic intermediate filaments in Gastrointestinal smooth muscle cells. The C-terminal CAAX box undergoes isoprenylation and carboxymethylation by enzymes such as Farnesyltransferase and Isoprenylcysteine carboxyl methyltransferase, processes shared with Ras proteins, which promote membrane association at the inner nuclear membrane near complexes like the Nuclear pore complex. Structural studies draw on methods used by groups associated with European Molecular Biology Laboratory and Max Planck Institute for Biophysical Chemistry.

Gene and Expression

The LMNB1 gene resides on human chromosome 5 and is regulated by promoter elements responsive to transcription factors including E2F1, SP1, and NF-Y, paralleling regulatory networks observed for cell cycle genes such as Cyclin B1 and PCNA. LMNB1 expression peaks in proliferative tissues of embryos examined by teams at institutions like Harvard University and Stanford University and is downregulated during terminal differentiation in experiments from labs at Karolinska Institutet and University of Cambridge. Alternative promoters, transcriptional control by microRNAs akin to miR-9 and miR-23a, and chromatin context involving loci characterized by consortia such as the ENCODE Project influence LMNB1 transcriptional dynamics across cell types including neurons, fibroblasts, and hepatocytes.

Cellular Functions

Lamin B1 contributes to nuclear mechanical integrity, chromatin tethering, and replication timing by interacting with membrane proteins like Emerin and Lamin B receptor, reminiscent of scaffold functions described for Scaffold attachment factor A. It organizes lamina-associated domains (LADs) that overlap with genomic regions studied by groups using techniques developed at Broad Institute and Wellcome Trust Sanger Institute, affecting gene repression as seen in developmental programs studied in Xenopus laevis and Zebrafish. During mitosis, Lamin B1 is disassembled by phosphorylation events coordinated by kinases such as CDK1 and PKC, following patterns characterized in research from Max Planck Institute for Molecular Cell Biology and Genetics and Cold Spring Harbor Laboratory. Lamin B1 also influences nuclear pore distribution, interacting functionally with factors characterized at European Molecular Biology Laboratory and EMBL-EBI.

Role in Development and Aging

LMNB1 is essential for embryogenesis; knockout models in Mus musculus demonstrate defects paralleling developmental phenotypes reported in studies from National Institutes of Health intramural programs. Differential Lamin B1 levels guide lineage decisions during neurogenesis investigated by teams at MIT and Columbia University, and perturbation of Lamin B1 alters cortical development in models used by laboratories at University College London. Age-associated decline or misregulation of Lamin B1 is a hallmark of cellular senescence described in seminal work at Stanford University and University of Oxford, linking Lamin B1 loss to chromatin reorganization similar to changes characterized in replicative senescence studies by researchers at The Salk Institute and Max Planck Institute for Biology of Ageing.

Clinical Significance and Disease Associations

Alterations in LMNB1 dosage and function are implicated in disorders including autosomal dominant adult-onset leukodystrophy (ADLD) linked to LMNB1 gene duplications identified in clinical genetics consortia at Mayo Clinic and Johns Hopkins Hospital. Laminopathies affecting other lamins, such as mutations in LMNA causing Emery–Dreifuss muscular dystrophy and Hutchinson–Gilford progeria syndrome described by investigators at NIH and University of Pennsylvania, provide context for nuclear envelope disease mechanisms. Reduced Lamin B1 is associated with neurodegenerative processes studied by groups at University of California, San Francisco and Karolinska Institutet and is observed in models of Alzheimer's disease and Parkinson's disease. LMNB1 expression changes have been reported in cancer cohorts analyzed by The Cancer Genome Atlas and can influence genomic instability characterized in studies at Dana-Farber Cancer Institute.

Interactions and Post-translational Modifications

Lamin B1 interacts with nuclear envelope components such as Emerin, Lamin B receptor, and chromatin modifiers including members of the Polycomb Group complexes and Histone deacetylase 3; these interactions mirror networks mapped by the Human Protein Atlas and proteomics efforts at European Bioinformatics Institute. Post-translational modifications include farnesylation by Farnesyltransferase, phosphorylation by CDK1 and PKC during the cell cycle, and ubiquitination pathways involving ligases studied at Cold Spring Harbor Laboratory and EMBL. Sumoylation and acetylation have been reported in proteomic screens from consortia such as Proteomics Standards Initiative, modulating Lamin B1's assembly and chromatin-binding properties in ways comparable to regulatory mechanisms described for Histone H3 and p53.

Category:Nuclear lamina proteins Category:Human proteins